{
    "2018-09-04": [
        [
            {
                "time": "",
                "original_text": "处方药压力渐显，非药景气依旧｜【光大医药·2018H1总结】",
                "features": {
                    "keywords": [
                        "处方药",
                        "压力",
                        "非药",
                        "景气"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业半年报见喜繁荣后存忧",
                "features": {
                    "keywords": [
                        "医药行业",
                        "半年报",
                        "繁荣",
                        "忧"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "招商证券：医药行业维持较高景气 关注优质白马及高成长个股",
                "features": {
                    "keywords": [
                        "招商证券",
                        "医药行业",
                        "景气",
                        "优质白马",
                        "高成长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "机构动向：外资减消费加周期 私募在“吃面",
                "features": {
                    "keywords": [
                        "机构动向",
                        "外资",
                        "消费",
                        "周期",
                        "私募"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费",
                        "周期"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "MSCI中国指数新加入10只成分股 蓝筹股投资价值有望凸显",
                "features": {
                    "keywords": [
                        "MSCI中国指数",
                        "成分股",
                        "蓝筹股",
                        "投资价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "蓝筹股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}